DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 48 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $46,000 | -16.4% | 14,518 | -10.4% | 0.02% | 0.0% |
| Q1 2017 | $55,000 | -31.2% | 16,204 | -41.5% | 0.02% | -14.3% |
| Q4 2016 | $80,000 | -12.1% | 27,704 | -9.0% | 0.02% | +23.5% |
| Q2 2016 | $91,000 | -91.5% | 30,429 | -60.2% | 0.02% | -83.7% |
| Q2 2015 | $1,065,000 | +200.0% | 76,364 | +173.6% | 0.10% | +235.5% |
| Q3 2014 | $355,000 | +52.4% | 27,914 | +170.2% | 0.03% | +72.2% |
| Q2 2014 | $233,000 | – | 10,332 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |